PD-1/PDL1 and CD28/CD80 pathways modulate natural killer T cell function to inhibit hepatitis B virus replication. - Wikidata - wikimedia - TriplyDB

PD-1/PDL1 and CD28/CD80 pathways modulate natural killer T cell function to inhibit hepatitis B virus replication.

PD-1/PDL1 and CD28/CD80 pathways modulate natural killer T cell function to inhibit hepatitis B virus replication.

http://www.wikidata.org/entity/Q42271423

about

Innate immune targets of hepatitis B virus infection Forsythoside A Inhibits BVDV Replication via TRAF2-Dependent CD28–4-1BB Signaling in Bovine PBMCs Integrative analysis of differentially expressed microRNAs of pulmonary alveolar macrophages from piglets during H1N1 swine influenza A virus infection Natural killer T (NKT) cells in autoimmune hepatitis Changes of costimulatory molecule CD28 on circulating CD8+ T cells correlate with disease pathogenesis of chronic hepatitis B PD-1 Blockade in Advanced Melanoma in Patients with Hepatitis C and/or HIV.The development of adult innate lymphoid cells.Immunological basis of stem cell therapy in liver diseases.Adoptive cellular therapy of cancer: exploring innate and adaptive cellular crosstalk to improve anti-tumor efficacy.Exploring the Therapeutic Potentials of iNKT Cells for Anti-HBV Treatment.Adoptive Cellular Therapy (ACT) for Cancer Treatment.Mixed Signals: Co-Stimulation in Invariant Natural Killer T Cell-Mediated Cancer Immunotherapy.The induction of autoimmune hepatitis in the human leucocyte antigen-DR4 non-obese diabetic mice autoimmune hepatitis mouse model.Tim-3 blockade promotes iNKT cell function to inhibit HBV replication.

P2860

Q26743647-42F8586A-C818-4C44-B730-47DB4F42C7C8 Q27468726-AE2B6721-3AC0-4707-B86E-0D9819F5DAF2 Q30371291-7D464D15-2A4C-4964-A7C8-F0427588683D Q33580295-9A2B11CF-6A05-445B-B1C2-A50663CE7B8C Q33809735-251FD70B-01FB-4AC4-9BA2-929640A5A4AC Q36089136-15059A92-D594-4131-9D7C-80159796CA06 Q36711915-39E5EC81-97F9-459F-BF4C-B67FDF86EF80 Q38223210-F1AB0445-6663-4457-942C-5A0623B86108 Q38258842-2F4E2A66-EDAF-4336-848D-0C0DB052DE8F Q38273315-83718FBE-B548-4F10-91A3-50EBCBF3F7E3 Q38848219-6FBCC576-CFAB-4F10-AB72-20F0358C18BE Q47094171-F27F5A04-CD73-4513-B1A7-F86B6710494B Q49036478-E5E641E6-83CF-499D-8D56-7F21ED7CBD00 Q54965814-3D1F193A-66D0-49C2-BD3C-C820F508E788

P2860

PD-1/PDL1 and CD28/CD80 pathways modulate natural killer T cell function to inhibit hepatitis B virus replication.

http://www.wikidata.org/entity/Q42271423

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

PD-1/PDL1 and CD28/CD80 pathwa ...... hepatitis B virus replication.

@en

PD-1/PDL1 and CD28/CD80 pathwa ...... hepatitis B virus replication.

@nl

type

label

PD-1/PDL1 and CD28/CD80 pathwa ...... hepatitis B virus replication.

@en

PD-1/PDL1 and CD28/CD80 pathwa ...... hepatitis B virus replication.

@nl

prefLabel

PD-1/PDL1 and CD28/CD80 pathwa ...... hepatitis B virus replication.

@en

PD-1/PDL1 and CD28/CD80 pathwa ...... hepatitis B virus replication.

@nl

P1433

Q42271423-5416F594-CAE7-4949-A0C3-21936F178902

P1476

Q42271423-A889324A-0E04-44C1-A246-710771BDDCE4

P2093

Q42271423-1866218B-2195-47F5-8A77-30DBAC0348C9

Q42271423-6E0B4211-2E0B-47BC-A8E8-E1FE14632CA2

Q42271423-B322471A-7795-4A97-A3BF-AA67FAD847EB

Q42271423-B63DC702-2FAB-48E4-850B-43ECB16350BC

Q42271423-C3F12BF9-024D-4B39-BBF7-B1F63D191FBA

Q42271423-E7543D9E-482E-48AD-B76A-D90D0CC71A07

P2860

Q42271423-00A5B50A-0E3E-4654-B676-9E74E657B3FA

Q42271423-02FDEF5A-AE11-4B31-832D-51A96B15AFAB

Q42271423-12E56D77-3019-4663-AF54-25B1CB8932F2

Q42271423-1A75FDFE-29D8-4D10-845F-536348CBCA9A

Q42271423-1ADD5E05-F050-4FBC-BBBC-1BD521A672EC

Q42271423-2859A8ED-91DC-43AC-BA1D-10A4C889F7DA

Q42271423-30A418F3-30EA-48B3-9286-A0B95FF1FD78

Q42271423-3A03357C-70AA-4F28-B495-8666ADD1F7F5

Q42271423-5836467C-A29C-44B8-BC5A-F545233255D1

Q42271423-6CA309EB-60F5-4FB6-BCF0-6FE4E66D8E73

P304

Q42271423-46AE6F1E-4299-4EC5-83A8-485EF8FD1266

P31

Q42271423-0F67C17F-7979-4245-8FEF-3566C03CC562

P356

Q42271423-ED918057-26A2-4BB1-BC99-188FDC1E856B

P478

Q42271423-5BFFFC4B-B9C1-498C-838A-8FC23EB7A934

P577

Q42271423-E723ECA8-8A4D-4B3E-9EA6-9253CE724ADE

P698

Q42271423-934DB579-8024-4D80-B099-EA6420C49BEF

P356

P1433

Journal of Viral Hepatitis

P1476

PD-1/PDL1 and CD28/CD80 pathwa ...... hepatitis B virus replication.

@en

P2093

C B Chen

http://www.w3.org/2001/XMLSchema#string

H Ren

http://www.w3.org/2001/XMLSchema#string

M Chen

http://www.w3.org/2001/XMLSchema#string

T D Shi

http://www.w3.org/2001/XMLSchema#string

X F Wang

http://www.w3.org/2001/XMLSchema#string

Y Lei

http://www.w3.org/2001/XMLSchema#string

P2860

CD28 co-stimulation down regulates Th17 development

Costimulatory molecule programmed death-1 in the cytotoxic response during chronic hepatitis C

The maze of treatments for hepatitis B

The biology of NKT cells

PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cells

Modulation of NKT cell development by B7-CD28 interaction: an expanding horizon for costimulation.

Immune effectors required for hepatitis B virus clearance

PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions.

Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines.

Severe functional impairment and elevated PD-1 expression in CD1d-restricted NKT cells retained during chronic HIV-1 infection

P304

27-39

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JVH.12061

http://www.w3.org/2001/XMLSchema#string

P478

20 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23458522

http://www.w3.org/2001/XMLSchema#string